Article Details

Pepaxto's US uptake to stall in multiple myeloma until FDA provides advice to address death risk

Retrieved on: 2021-08-05 16:54:07

Tags for this article:

Click the tags to see associated articles and topics

Pepaxto's US uptake to stall in multiple myeloma until FDA provides advice to address death risk. View article details on hiswai:

Excerpt

Data analysis on subgroups, specifically on patients' previous therapies or subsequent therapies may help find Pepaxto niches; Prophylactic antibiotics ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up